1 |
García-Cortés M, Ortega-Alonso A, Andrade RJ. Safety of treating acute liver injury and failure. Expert Opin Drug Saf 2021;:1-13. [PMID: 34254839 DOI: 10.1080/14740338.2021.1955854] [Reference Citation Analysis]
|
2 |
Lozano-Ruiz B, González-Navajas JM. The Emerging Relevance of AIM2 in Liver Disease. Int J Mol Sci 2020;21:E6535. [PMID: 32906750 DOI: 10.3390/ijms21186535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
3 |
Ntonas A, Katsourakis A, Galanis N, Filo E, Noussios G. Comparative Anatomical Study Between the Human and Swine Liver and Its Importance in Xenotransplantation. Cureus 2020;12:e9411. [PMID: 32864240 DOI: 10.7759/cureus.9411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
4 |
Mathew J, Gnanaraj J, Basavarajegowda A, Venkateswaran R. Plasmapheresis in lethal yellow phosphorus poisoning: a scope for recovery. BMJ Case Rep 2021;14:e239676. [PMID: 33883110 DOI: 10.1136/bcr-2020-239676] [Reference Citation Analysis]
|
5 |
Zhang S, Jiang L, Hu H, Wang H, Wang X, Jiang J, Ma Y, Yang J, Hou Y, Xie D, Zhang Q. Pretreatment of exosomes derived from hUCMSCs with TNF-α ameliorates acute liver failure by inhibiting the activation of NLRP3 in macrophage. Life Sci 2020;246:117401. [PMID: 32035931 DOI: 10.1016/j.lfs.2020.117401] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
|
6 |
Xu D, Zhao Z, Li Y, Shang C, Liu L, Yan J, Zheng Y, Wen Z, Gu T. Inhibition of O-glycosylation aggravates GalN/LPS-induced liver injury through activation of ER stress. Immunopharmacol Immunotoxicol 2021;43:741-8. [PMID: 34549685 DOI: 10.1080/08923973.2021.1979035] [Reference Citation Analysis]
|